Expression of ERα36 in gastric cancer samples and their matched normal tissues

Oncology Letters

Volumn 3, Issue 1, 2012, Pages 172-175

  Wang, Jianjun ^a   Li, Jiajia ^b   Fang, Rengui ^a   Xie, Shuduo ^c   Wang, Linbo ^c   Xu, Chaoyang ^b,c  

^a The Chunan County First Hospital   (China)

^b SHAOXING UNIVERSITY   (China)

^c ZHEJIANG UNIVERSITY   (China)

Author keywords

Estrogen receptor 36; Estrogen receptor 66; Gastric cancer; Polymerase chain reaction; Variation

Indexed keywords

ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR ALPHA36; ESTROGEN RECEPTOR ALPHA66; MESSENGER RNA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MALE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; STOMACH CANCER; TISSUE DISTRIBUTION;

EID: 84855211437     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2011.437     Document Type: Article

References (22)

1. Freedman ND, Ahn J, Hou L, et al: Polymorphisms in estrogen- and androgen-metabolizing genes and the risk of gastric cancer. Carcinogenesis 30: 71-77, 2009.
2. Xu CY, Guo JL, Jiang ZN, et al: Prognostic role of estrogen receptor alpha and estrogen receptor beta in gastric cancer. Ann Surg Oncol 17: 2503-2509, 2010.
3. Wang Z, Zhang X, Shen P, et al: Identification, cloning, and expression of human estrogen receptor-alpha36, a novel variant of human estrogen receptor-alpha66. Biochem Biophys Res Commun 336: 1023-1027, 2005.
4. Shi L, Dong B, Li Z, et al: Expression of ER-{alpha}36, a novel variant of estrogen receptor {alpha}, and resistance to tamoxifen treatment in breast cancer. J Clin Oncol 20: 3423-3429, 2009.
5. Lee LM, Cao J, Deng H, et al: ER-alpha36, a novel variant of ER-alpha, is expressed in ER-positive and -negative human breast carcinomas. Anticancer Res 28: 479-483, 2008.
6. Jiang H, Teng R, Wang Q, et al: Transcriptional analysis of estrogen receptor alpha variant mRNAs in colorectal cancers and their matched normal colorectal tissues. J Steroid Biochem Mol Biol 112: 20-24, 2008.
7. Lin SL, Yan LY, Liang XW, et al: A novel variant of ER-alpha, ER-alpha36 mediates testosterone-stimulated ERK and Akt activation in endometrial cancer Hec1A cells. Reprod Biol Endocrinol 24: 102, 2009.
8. Wang Z, Zhang X, Shen P, et al: A variant of estrogen receptor-{alpha}, hER-{alpha}36: transduction of estrogen- and antiestrogen-dependent membrane-initiated mitogenic signaling. Proc Natl Acad Sci USA 103: 9063-9068, 2006.
9. Sobin LH, Wittekind C: UICC: TNM Classification of Malignant Tumours, ed 5. London, Wiley, 1997.
10. Schmittgen TD and Livak KJ: Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3: 1101-1108, 2008.
11. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T). Method Methods 25: 402-408, 2001.
12. Jiang HP, Teng RY, Wang Q, et al: Estrogen receptor alpha variant ERalpha46 mediates growth inhibition and apoptosis of human HT-29 colon adenocarcinoma cells in the presence of 17beta-oestradiol. Chin Med J (Engl) 121: 1025-1031, 2008.
13. Chandanos E, Rubio CA, Lindblad M, et al: Endogenous estrogen exposure in relation to distribution of histological type and estrogen receptors in gastric adenocarcinoma. Gastric Cancer 11: 168-174, 2008.
14. Kameda C, Nakamura M, Tanaka H, et al: Oestrogen receptor-alpha contributes to the regulation of the hedgehog signalling pathway in ERalpha-positive gastric cancer. Br J Cancer 16: 738-747, 2010.
15. Zhao XH, Gu SZ, Liu SX, et al: Expression of estrogen receptor and estrogen receptor messenger RNA in gastric carcinoma tissues. World J Gastroenterol 9: 665-669, 2003.
16. Wang M, Pan JY, Song GR, et al: Altered expression of estrogen receptor alpha and beta in advanced gastric adenocarcinoma: correlation with prothymosin alpha and clinicopathological parameters. Eur J Surg Oncol 33: 195-201, 2007.
17. Oshima CT, Wonraht DR, Catarino RM, Mattos D and Forones NM: Estrogen and progesterone receptors in gastric and colorectal cancer. Hepatogastroenterology 46: 3155-3158, 1999.
18. Raso MG, Behrens C, Herynk MH, et al: Immunohistochemical expression of estrogen and progesterone receptors identifies a subset of NSCLCs and correlates with EGFR mutation. Clin Cancer Res 15: 5359-5368, 2009.
19. Nüssler NC, Reinbacher K, Shanny N, et al: Sex-specific differences in the expression levels of estrogen receptor subtypes in colorectal cancer. Gend Med 5: 209-217, 2008.
20. Chandanos E, Lindblad M, Rubio CA, et al: Tamoxifen exposure in relation to gastric adenocarcinoma development. Eur J Cancer 44: 1007-1014, 2008.
21. Izawa M, Inoue M, Osaki M, et al: Cytochrome P450 aromatase gene (CYP19) expression in gastric cancer. Gastric Cancer 11: 103-110, 2008.
22. Harrison JD, Morris DL, Ellis IO, Jones JA and Jackson I: The effect of tamoxifen and estrogen receptor status on survival in gastric carcinoma. Cancer 64: 1007-1010, 1989.